Transgenic overexpression of keratinocyte-specific VEGF and Ang1 in combination promotes wound healing under nondiabetic but not diabetic conditions

International Journal of Clinical and Experimental Pathology

Volumn 5, Issue 1, 2012, Pages 1-11

  Loyd, Candace M ^a,b   Diaconu, Doina ^a,b   Fu, Wen ^a,b   Adams, Gregory N ^a,b   Brandt, Erin ^a,b   Knutsen, Dorothy A ^a,b   Wolfram, Julie A ^a,b   McCormick, Thomas S ^a,b   Ward, Nicole L ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Angiogenesis; Keratinocyte; Re epithelialization; Skin; Streptozotocin; Transgenic mouse; Wound healing

Indexed keywords

ANGIOPOIETIN 1; ANGPT1 PROTEIN, MOUSE; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL; ARTICLE; BIOSYNTHESIS; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL DIABETES MELLITUS; GENETICS; KERATINOCYTE; MALE; METABOLISM; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENE; TRANSGENIC MOUSE; WESTERN BLOTTING; WOUND HEALING;

ANGIOPOIETIN-1; ANIMALS; BLOTTING, WESTERN; DIABETES MELLITUS, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; KERATINOCYTES; MALE; MICE; MICE, TRANSGENIC; NEOVASCULARIZATION, PHYSIOLOGIC; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSGENES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 84856697787     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. American Diabetes Association. Economic costs of diabetes in the US In 2007. Diabetes Care 2008; 31: 596-615.
2. Martin A, Komada MR and Sane DC. Abnormal angiogenesis in diabetes mellitus. Med Res Rev 2003; 23: 117-145.
3. Gibran NS, Jang YC, Isik FF, Greenhalgh DG, Muffley LA, Underwood RA, Usui ML, Larsen J, Smith DG, Bunnett N, Ansel JC and Olerud JE. Diminished neuropeptide levels contribute to the impaired cutaneous healing response associated with diabetes mellitus. J Surg Res 2002; 108: 122-128.
4. Wetzler C, Kampfer H, Stallmeyer B, Pfeilschifter J and Frank S. Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. J Invest Dermatol 2000; 115: 245-253.
5. Lan CC, Liu IH, Fang AH, Wen CH and Wu CS. Hyperglycaemic conditions decrease cultured keratinocyte mobility: implications for impaired wound healing in patients with diabetes. Br J Dermatol 2008; 159: 1103-1115.
6. Kampfer H, Pfeilschifter J and Frank S. Expressional regulation of angiopoietin-1 and -2 and the tie-1 and -2 receptor tyrosine kinases during cutaneous wound healing: a comparative study of normal and impaired repair. Lab Invest 2001; 81: 361-373.
7. Frank S, Hubner G, Breier G, Longaker MT, Greenhalgh DG and Werner S. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem 1995; 270: 12607-12613.
8. Menke NB, Ward KR, Witten TM, Bonchev DG and Diegelmann RF. Impaired wound healing. Clinics in Dermatology 2007; 25: 19-25.
9. Stadelmann WK, Digenis AG and Tobin GR. Impediments to wound healing. Am J Surg 1998; 176: 39S-47S.
10. Martin P. Wound Healing-Aiming for Perfect Skin Regeneration. Science 1997; 276: 75-81.
11. Kirchner LM, Meerbaum SO, Gruber BS, Knoll AK, Bulgrin J, Taylor RA and Schmidt SP. Effects of vascular endothelial growth factor on wound closure rates in the genetically diabetic mouse model. Wound Repair Regen 2003; 11: 127-131.
12. Vranckx JJ, Yao F, Petrie N, Augustinova H, Hoeller D, Visovatti S, Slama J and Eriksson E. In vivo gene delivery of Ad-VEGF to fullthickness wounds in aged pigs results in high levels of VEGF expression but not in accelerated healing. Wound Repair Regen 2005; 13: 51-60.
13. Stallmeyer B, Pfeilschifter J and Frank S. Systemically and topically supplemented leptin fails to reconstitute a normal angiogenic response during skin repair in diabetic ob/ob mice. Diabetologia 2001; 44: 471-479.
14. Bohlen HG, Niggl BA. Adult microvascular disturbances as a result of juvenile onset diabetes in Db/Db mice. Blood Vessels 1979; 16: 269-276.
15. Greenhalgh DG, Sprugel KH, Murray MJ and Ross R. PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am J Pathol 1990; 136: 1235-1246.
16. Sivan-Loukianova E, Awad OA, Stepanovic V, Bickenbach J and Schatteman GC. CD34+ blood cells accelerate vascularization and healing of diabetic mouse skin wounds. J Vasc Res 2003; 40: 368-377.
17. Galiano RD, Tepper OM, Pelo CR, Bhatt KA, Callaghan M, Bastidas N, Bunting S, Steinmetz HG and Gurtner GC. Topical Vascular Endothelial Growth Factor Accelerates Diabetic Wound Healing through Increased Angiogenesis and by Mobilizing and Recruiting Bone Marrow-Derived Cells. Am J Pathol 2004; 164: 1935-1947.
18. Wall SJ, Bevan D, Thomas DW, Harding KG, Edwards DR and Murphy G. Differential expression of matrix metalloproteinases during impaired wound healing of the diabetes mouse. J Invest Dermatol 2002; 119: 91-98.
19. Loomans CJM, de Koning EJP, Staal FJT, Rookmaaker MB, Verseyden C, de Boer HC, Verhaar MC, Braam B, Rabelink TJ and van Zonneveld A -J. Endothelial Progenitor Cell Dysfunction: A Novel Concept in the Pathogenesis of Vascular Complications of Type 1 Diabetes. Diabetes 2004; 53: 195-199.
20. Sheetz MJ, King GL. Molecular understanding of hyperglycemia's adverse effects for diabetic complications. Jama 2002; 288: 2579-2588.
21. Brown LF, Yeo KT, Berse B, Yeo TK, Senger DR, Dvorak HF and van de Water L. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 1992; 176: 1375-1379.
22. Altavilla D, Saitta A, Cucinotta D, Galeano M, Deodato B, Colonna M, Torre V, Russo G, Sardella A, Urna G, Campo GM, Cavallari V, Squadrito G and Squadrito F. Inhibition of Lipid Peroxidation Restores Impaired Vascular Endothelial Growth Factor Expression and Stimulates Wound Healing and Angiogenesis in the Genetically Diabetic Mouse. Diabetes 2001; 50: 667-674.
23. Corral CJ, Siddiqui A, Wu L, Farrell CL, Lyons D and Mustoe TA. Vascular endothelial growth factor is more important than basic fibroblastic growth factor during ischemic wound healing. Arch Surg 1999; 134: 200-205.
24. Galeano M, Deodato B, Altavilla D, Cucinotta D, Arsic N, Marini H, Torre V, Giacca M and Squadrito F. Adeno-associated viral vectormediated human vascular endothelial growth factor gene transfer stimulates angiogenesis and wound healing in the genetically diabetic mouse. Diabetologia 2003; 46: 546-555.
25. Lim HS, Blann AD, Chong AY, Freestone B and Lip GYH. Plasma Vascular Endothelial Growth Factor, Angiopoietin-1, and Angiopoietin-2 in Diabetes: Implications for cardiovascular risk and effects of multifactorial intervention Diabetes Care 2004; 27: 2918-2924.
26. Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D, Yancopoulos GD and Wiegand SJ. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 1999; 284: 1994-1998.
27. Hanahan D. Signaling vascular morphogenesis and maintenance. Science 1997; 277: 48-50.
28. Lobov IB, Brooks PC and Lang RA. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proceedings of the National Academy of Sciences of the United States of America 2002; 99: 11205-11210.
29. Pichiule P, LaManna JC. Angiopoietin-2 and rat brain capillary remodeling during adaptation and deadaptation to prolonged mild hypoxia. Journal of Applied Physiology 2002; 93: 1131-1139.
30. Puri MC, Partanen J, Rossant J and Bernstein A. Interaction of the TEK and TIE receptor tyrosine kinases during cardiovascular development. Development 1999; 126: 4569-4580.
31. Jones N, Voskas D, Master Z, Sarao R, Jones J and Dumont DJ. Rescue of the early vascular defects in Tek/Tie2 null mice reveals an essential survival function. EMBO Rep 2001; 2: 438-445.
32. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN and Yancopoulos GD. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277: 55-60.
33. Jacobi J, Tam BY, Sundram U, von Degenfeld G, Blau HM, Kuo CJ and Cooke JP. Discordant effects of a soluble VEGF receptor on wound healing and angiogenesis. Gene Ther 2004; 11: 302-309.
34. Thurston G. Complementary actions of VEGF and angiopoietin-1 on blood vessel growth and leakage. Journal of anatomy 2002; 200: 575-580.
35. Thurston G, Suri C, Smith K, McClain J, Sato TN, Yancopoulos GD and McDonald DM. Leakageresistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 1999; 286: 2511-2514.
36. Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, Croll SD, Glazer N, Holash J, McDonald DM and Yancopoulos GD. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nature medicine 2000; 6: 460-463.
37. Jain RK, Munn LL. Leaky vessels? Call Ang1! Nature medicine 2000; 6: 131-132.
38. Bitto A, Minutoli L, Galeano MR, Altavilla D, Polito F, Fiumara T, Calo M, Lo Cascio P, Zentilin L, Giacca M and Squadrito F. Angiopoietin-1 gene transfer improves impaired wound healing in genetically diabetic mice without increasing VEGF expression. Clin Sci (Lond) 2008; 114: 707-718.
39. Cho CH, Sung HK, Kim KT, Cheon HG, Oh GT, Hong HJ, Yoo OJ and Koh GY. COMPangiopoietin-1 promotes wound healing through enhanced angiogenesis, lymphangiogenesis, and blood flow in a diabetic mouse model. Proc Natl Acad Sci USA 2006; 103: 4946-4951.
40. Van Slyke P, Alami J, Martin D, Kuliszewski M, Leong-Poi H, Sefton MV and Dumont D. Acceleration of diabetic wound healing by an angiopoietin peptide mimetic. Tissue Eng Part A 2009; 15: 1269-1280.
41. Ward NL, Hatala DA, Wolfram JA, Knutsen DA and Loyd CM. Cutaneous manipulation of vascular growth factors leads to alterations in immunocytes, blood vessels and nerves: Evidence for a cutaneous neurovascular unit. Journal of Dermatological Science 2011; 61: 14-22.
42. Wolfram JA, Diaconu D, Hatala DA, Rastegar J, Knutsen DA, Lowther A, Askew D, Gilliam AC, McCormick TS and Ward NL. Keratinocyte but not endothelial cell specific overexpression of Tie2 leads to the development of psoriasis. Am J Pathol 2009; 174: 1443-1458.
43. Caldelari R, Suter MM, Baumann D, De Bruin A and Muller E. Long-term culture of murine epidermal keratinocytes. J Invest Dermatol 2000; 114: 1064-1065.
44. Nishiyama T, Kii I, Kashima TG, Kikuchi Y, Ohazama A, Shimazaki M, Fukayama M and Kudo A. Delayed re-epithelialization in periostindeficient mice during cutaneous wound healing. PLoS One 2011; 6: e18410.
45. Ward NL, Slyke PV and Dumont DJ. Functional inhibition of secreted angiopoietin: a novel role for angiopoietin 1 in coronary vessel patterning. Biochemical and Biophysical Research Communications 2004; 323: 937-946.
46. Chen X, Fu W, Tung CE and Ward NL. Angiopoietin-1 induces neurite outgrowth of PC12 cells in a Tie2-independent, beta1-integrindependent manner. Neurosci Res 2009; 64: 348-354.
47. Ismail NS, Pravda EA, Li D, Shih SC and Dallabrida SM. Angiopoietin-1 Reduces H2O2-Induced Increases in Reactive Oxygen Species and Oxidative Damage to Skin Cells. J Invest Dermatol 2010; 130: 1307-1317.
48. Romano Di Peppe S, Mangoni A, Zambruno G, Spinetti G, Melillo G, Napolitano M and Capogrossi MC. Adenovirus-mediated VEGF(165) gene transfer enhances wound healing by promoting angiogenesis in CD1 diabetic mice. Gene Ther 2002; 9: 1271-1277.
49. Cao R, Brakenhielm E, Wahlestedt C, Thyberg J and Cao Y. Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proceedings of the National Academy of Sciences 2001; 98: 6390-6395.
50. Garonna E, Botham KM, Birdsey GM, Randi AM, Gonzalez-Perez RR and Wheeler-Jones CPD. Vascular Endothelial Growth Factor Receptor-2 Couples Cyclo-Oxygenase-2 with Pro-Angiogenic Actions of Leptin on Human Endothelial Cells. PLoS ONE 2011; 6: e18823.
51. Cao Y. Angiogenesis modulates adipogenesis and obesity. The Journal of Clinical Investigation 2007; 117: 2362-2368.